CN118922429A - 异常磷酸化和tau蛋白聚集的抑制剂 - Google Patents
异常磷酸化和tau蛋白聚集的抑制剂 Download PDFInfo
- Publication number
- CN118922429A CN118922429A CN202280089714.7A CN202280089714A CN118922429A CN 118922429 A CN118922429 A CN 118922429A CN 202280089714 A CN202280089714 A CN 202280089714A CN 118922429 A CN118922429 A CN 118922429A
- Authority
- CN
- China
- Prior art keywords
- tau
- compound
- amide
- nmr
- sulfonic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306658.2 | 2021-11-29 | ||
| EP21306658 | 2021-11-29 | ||
| PCT/EP2022/083709 WO2023094699A1 (fr) | 2021-11-29 | 2022-11-29 | Inhibiteurs de la phosphorylation anormale et de l'agrégation de la protéine tau |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118922429A true CN118922429A (zh) | 2024-11-08 |
Family
ID=78851140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280089714.7A Pending CN118922429A (zh) | 2021-11-29 | 2022-11-29 | 异常磷酸化和tau蛋白聚集的抑制剂 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250034194A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4441064A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024543187A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118922429A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3240163A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023094699A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240409505A1 (en) * | 2023-06-12 | 2024-12-12 | The Procter & Gamble Company | Gluconamide sulfate surfactants |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686603A (en) * | 1995-05-04 | 1997-11-11 | Lever Brothers Company, Division Of Conopco, Inc. | Sulfated polyhydroxy compounds as anionic surfactants and a process for their manufacture |
| WO2007115372A1 (en) * | 2006-04-10 | 2007-10-18 | Monash University | A method of modulating beta-amyloid peptide production |
-
2022
- 2022-11-29 CA CA3240163A patent/CA3240163A1/fr active Pending
- 2022-11-29 JP JP2024531728A patent/JP2024543187A/ja active Pending
- 2022-11-29 WO PCT/EP2022/083709 patent/WO2023094699A1/fr not_active Ceased
- 2022-11-29 CN CN202280089714.7A patent/CN118922429A/zh active Pending
- 2022-11-29 EP EP22823041.3A patent/EP4441064A1/fr active Pending
- 2022-11-29 US US18/714,018 patent/US20250034194A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250034194A1 (en) | 2025-01-30 |
| CA3240163A1 (fr) | 2023-06-01 |
| WO2023094699A1 (fr) | 2023-06-01 |
| JP2024543187A (ja) | 2024-11-19 |
| EP4441064A1 (fr) | 2024-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3402801B1 (en) | Cyclic dinucleotides for treating conditions associated with sting activity such as cancer | |
| JP7590185B2 (ja) | Taireファミリーキナーゼインヒビターおよびそれらの使用 | |
| CN112020358A (zh) | 诱导蛋白质选择性降解的小分子及其用途 | |
| KR20140091459A (ko) | 항바이러스 치료용 2''-플루오로 치환된 카바-누클레오시드 유사체 | |
| TW202039426A (zh) | 泛硫醇(Pantetheine)衍生物及其用途 | |
| JP2022523864A (ja) | ニコチンアミドリボシドのリン誘導体を含む組成物及びニコチンアミドアデニンジヌクレオチドのモジュレーションのための方法 | |
| AU2017363313A1 (en) | Inhibitors of interleukin-1 receptor-associated kinases and uses thereof | |
| KR20180075630A (ko) | [1,2,4]트리아졸로[1,5-a]피리미딘-7-일 화합물 | |
| TR201815961T4 (tr) | Yeni sitostatik 7-deazapürin nükleozidleri. | |
| BR112013001553A2 (pt) | Métodos e compostos para tratar infecções por vírus paramyxoviridae | |
| EP3356447A1 (en) | Inhibitors of menaquinone biosynthesis | |
| JP2013537225A (ja) | 変異cftrタンパク質の修飾因子としての化合物及びcftrタンパク質異常に関連する病気の治療へのその使用 | |
| US20220249411A1 (en) | Calixarene compounds and uses thereof | |
| Hwang et al. | Synthetic phytoceramides induce apoptosis with higher potency than ceramides | |
| CN106892920A (zh) | 苦豆碱衍生物、其制备方法及用途 | |
| TW201241005A (en) | Methods for synthesizing molybdopterin precursor Z derivatives | |
| JP2018504411A (ja) | 感覚有毛細胞の死を防ぐまたは処置するための化合物と方法 | |
| WO2010142827A1 (es) | Propiedades neuroprotectoras de 5'-metiltioadenosina | |
| KR20140105598A (ko) | [1,2,4]트리아졸로피리딘 및 포스포디에스테라제 억제제로서의 이의 용도 | |
| US20250034194A1 (en) | Inhibitors of abnormal phosphorylation and tau protein aggregation | |
| TW201022279A (en) | Chemical compounds | |
| TWI803858B (zh) | 化合物及其醫藥用途 | |
| JP2008529998A (ja) | トポイソメラーゼII触媒インヒビターとしての6−エーテル/チオエーテル−プリンおよび療法(therapy)におけるその用途 | |
| JP2025505975A (ja) | ニコチネート及びニコチンアミドリボシドベースの化合物及びその誘導体 | |
| TW201922690A (zh) | 環-amp反應元素結合蛋白的抑制劑 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |